Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
89.3M
-
Shares change
-
+15.4M
-
Total reported value, excl. options
-
$306M
-
Value change
-
+$47.1M
-
Put/Call ratio
-
1.01
-
Number of buys
-
50
-
Number of sells
-
-64
-
Price
-
$3.43
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2022
145 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2022.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.3M shares
of 170M outstanding shares and own 52.4% of the company stock.
Largest 10 shareholders include FMR LLC (18.6M shares), FEDERATED HERMES, INC. (18M shares), Flagship Pioneering Inc. (14.4M shares), BlackRock Inc. (5.76M shares), JANUS HENDERSON GROUP PLC (5.37M shares), VANGUARD GROUP INC (5.33M shares), CVI Holdings, LLC (2.72M shares), STATE STREET CORP (1.46M shares), GEODE CAPITAL MANAGEMENT, LLC (1.22M shares), and Maven Securities LTD (1.15M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.